psalexa
logo

Animal Pharmaceuticals Market

Global Animal Pharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators, and Others), by Animal Type (Companion Animals and Production Animals)

Published: October 2016
Report Code: CP10742
Available Format:
Pages: 146

The research offers actual historical market size for the period 2012-2015 and market forecast for the period 2016-2022 in terms of U.S. dollars.
GLOBAL ANIMAL PHARMACEUTICALS MARKET

  • By Product
  • By Animal Type
  • By Region

GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT

  • Ectoparasiticides
    • Ivermectin
    • Cypermethrin
    • Fipronil
    • Coumaphos
    • Others
  • Endoparasiticides
    • Ivermectin
    • Praziquantel
    • Flubendazole
    • Milbemycin
    • Levamisole
    • Fenbendazole
    • Pyrantel
    • Others
  • Anti-Inflammatories
    • NSAIDs
    • Corticosteroids
    • Others
  • Bronchodilators
    • Theophylline
    • Albuterol
    • Others
  • Others

GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE

  • Companion Animals
    • Canine
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Firponil, and others
        • Endoparasiticides – Includes Praziquantel, Ivermectin, Milbemycin, Pyrantel, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Bronchodilators – Includes Theophylline, Albuterol, and Others
        • Others
    • Feline
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Firponil, and others
        • Endoparasiticides – Includes Praziquantel, Ivermectin, Milbemycin, Pyrantel, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Bronchodilators – Includes Theophylline, Albuterol, and Others
        • Others
    • Equine
      • By Product
        • Ectoparasiticides – Includes Cypermethrin, and others
        • Endoparasiticides – Includes Praziquantel, Ivermectin, Milbemycin, Pyrantel, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Bronchodilators – Includes Theophylline, Albuterol, and Others
        • Others
  • Production Animals
    • Livestock
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Cypermethrin, Coumaphos, and others
        • Endoparasiticides – Includes Ivermectin, Livamisole, Fenbendazole, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Others
    • Poultry
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Cypermethrin, Coumaphos, and Others
        • Endoparasiticides – Includes Flubendazole, and Others
        • Others

GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY GEOGRAPHY

North America Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – U.S., and Rest of North America
    • U.S. Animal Pharmaceuticals Market
      • By Product

Europe Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – Germany., France, U.K., Italy and Rest of Europe
    • Germany Animal Pharmaceuticals Market
      • By Product
    • France Animal Pharmaceuticals Market
      • By Product
    • U.K. Animal Pharmaceuticals Market
      • By Product
    • Italy Animal Pharmaceuticals Market
      • By Product

Asia-Pacific Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – China, India, Australia and Rest of Asia-Pacific
    • China Animal Pharmaceuticals Market
      • By Product
    • India Animal Pharmaceuticals Market
      • By Product
    • Australia Animal Pharmaceuticals Market
      • By Product

Rest of the World (RoW) Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – Brazil, and Rest of RoW
    • Brazil Animal Pharmaceuticals Market
  • By Product

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry